| Title : Sorafenib has soluble epoxide hydrolase inhibitory activity, which contributes to its effect profile in vivo - Liu_2009_Mol.Cancer.Ther_8_2193 |
| Author(s) : Liu JY , Park SH , Morisseau C , Hwang SH , Hammock BD , Weiss RH |
| Ref : Mol Cancer Ther , 8 :2193 , 2009 |
| Abstract : Liu_2009_Mol.Cancer.Ther_8_2193 |
| ESTHER : Liu_2009_Mol.Cancer.Ther_8_2193 |
| PubMedSearch : Liu_2009_Mol.Cancer.Ther_8_2193 |
| PubMedID: 19671760 |
Liu JY, Park SH, Morisseau C, Hwang SH, Hammock BD, Weiss RH (2009)
Sorafenib has soluble epoxide hydrolase inhibitory activity, which contributes to its effect profile in vivo
Mol Cancer Ther
8 :2193
Liu JY, Park SH, Morisseau C, Hwang SH, Hammock BD, Weiss RH (2009)
Mol Cancer Ther
8 :2193